Is InNexus Biotechnology Inc. stock (CVE:IXS), (PINK:IXSBF) really on the road to success again? The answer would be “yes”, considering Wednesday’s trading session results.
The company’s shares made a significant progress in terms of price and volume on the Canadian and on the American stock market.
On the TSX Venture Exchange, IXS price went up more than 12% and was $0.045 per share at closing. But it was the trading volume that made the big story. During the day, about 6.6 million shares changed…